Cost-Effectiveness Analysis of SGLT2 Inhibitors for Cardio-Renal-Metabolic Disease Based on Data from Japanese Studies

DOI: 10.1007/s12325-025-03157-z Publication Date: 2025-04-29T08:09:55Z